Risk factors for breast cancer–related lymphedema in patients undergoing 3years of prospective surveillance with intervention

BackgroundTo evaluate risk factors (treatment‐related, comorbidities, and lifestyle) for breast cancer–related lymphedema (BCRL) within the context of a Prospective Surveillance and Early Intervention (PSEI) model of care for subclinical BCRL.MethodsThe parent randomized clinical trial assigned pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2022-09, Vol.128 (18), p.3408-3415
Hauptverfasser:	Koelmeyer, Louise A, Gaitatzis, Katrina, Dietrich, Mary S, Shah, Chirag S, Boyages, John, McLaughlin, Sarah A, Taback, Bret, Stolldorf, Deonni P, Elder, Elisabeth, Hughes, T Michael, French, James R, Ngui, Nicholas, Hsu, Jeremy M, Moore, Andrew, Ridner, Sheila H
Format:	Artikel
Sprache:	eng
Schlagworte:	Air transportation Aircraft Body mass Body mass index Body size Breast cancer Cancer therapies Chemotherapy Comorbidity Compression Context Diabetes mellitus Hypertension Intervention Irradiation Lymph nodes Lymphedema Oncology Patients Radiation Risk analysis Risk factors Secondary analysis Spectroscopy Surveillance Taxanes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	BackgroundTo evaluate risk factors (treatment‐related, comorbidities, and lifestyle) for breast cancer–related lymphedema (BCRL) within the context of a Prospective Surveillance and Early Intervention (PSEI) model of care for subclinical BCRL.MethodsThe parent randomized clinical trial assigned patients newly diagnosed with breast cancer to PSEI with either bioimpedance spectroscopy (BIS) or tape measurement (TM). Surgical, systemic and radiation treatments, comorbidities, and lifestyle factors were recorded. Detection of subclinical BCRL (change from baseline of either BIS L‐Dex ≥6.5 or tape volume ≥ 5% and
ISSN:	0008-543X 1097-0142
DOI:	10.1002/cncr.34377